TransMed is an open access, peer-reviewed journal. The aim of TransMed is to serve the multidisciplinary community of nano biomedical engineering. Each quarterly issue of TransMed presents basic, clinical, and engineering research articles, reviews, highlights, conference proceedings, editorials and short communications in the interdisciplinary field of nanotechnology, biology, medicine and engineering, as well as strategies for disease prevention, diagnosis, treatment, and assessment.

Among the areas of interest the journal covers are:

1. Cancer biology and therapy: Tumor Microenvironment, Intratumoral Bacteria, Targeted Therapy, Epigenetics, Cell Therapy, Tumor Image, Ferroptosis, Chemoradiotherapy, Immunotherapy

2. Regenerative medicine: Pluripotent Stem Cells, Mesenchymal Stem Cells, Reprogramming, 3D Bioprinting, Hydrogel, Gene Editing, Exosome Therapy, Xenotransplantation, Organ-on-a-Chip, Synthetic Biology

3. Immunotherapy and immune system modulation: Immune Checkpoint Inhibitors, CAR-T Cell Therapy, Cancer Vaccines, Natural Killer Cell Therapy, STING Agonists, Immune Exclusion, Oncolytic Viruses, Cytokine Therapy, Gut Microbiome Modulation, Biomarker Discovery

4. Precision medicine and personalized treatments: Next-Generation Sequencing, Liquid Biopsy, Single-Cell Sequencing, Epigenomics, Pharmacogenomics, Antibody-Drug Conjugates, Personalized Cancer Vaccines, Digital Twin, Companion Diagnostics

5. Neurology and mental health therapies: Amyloid-β, α-Synuclein, Neuroinflammation, Monoamines, Gut-Brain Axis, Gene Therapy, Exosome Therapy, Brain Organoids, BBB Penetration.

6. Genetic and molecular research in medical applications: Gene Editing, Single-Cell Genomics, DNA Methylation, Histone Modifications, Non-coding RNA, mRNA Therapeutics, Spatial Transcriptomics, AI in Drug Discovery.

7. Drug delivery systems and biomaterials: Lipid Nanoparticles, Polymeric Micelles, Metal-Organic Frameworks, pH-Responsive Materials, ROS-Responsive Systems, Hydrogels, Active Targeting, Biomimetic Camouflage, Implantable Devices, Oral Biologics Delivery.

8. Clinical trial design and evidence-based medicine: Adaptive Design, Surrogate Endpoint, Expert Consensus, Biomarker Enrichment, Decentralized Clinical Trial, Real-World Data, Accelerated Approval, Dynamic Consent, Health Equity